RxDoctor Payments Data

Joshua Pan

Anesthesiology · Chicago, ILNPI 1346771201

Payments from drug & device makers

What this record shows

This record is dominated by grants: $33,182 of the $43,893 with a category attached, or 75.6%. 15 manufacturers reported payments, led by Abbott at 57.6% of the total. Reporting peaked in 2021 at $35,302 and has fallen 94.2% since, to $2,031 in 2025. Among anesthesiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,893in general payments, 2019–2025

Across 136 payments — averaging $322.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$25K
  • Medtronic$15K
  • Boston Scientific$1K
  • Nevro Corp.$634
  • MML US, Inc.$427
  • Biotronik NRO, Inc.$392
  • plus $505 from 9 others

What the payments were for

  • Grants$33,18276%
  • Travel & lodging$4,31410%
  • Food & beverage$6,39715%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,893 in reported general payments places this provider in the 95th percentile of 1,980 anesthesiology providers in Illinois.

See all anesthesiology providers in Illinois

Medicare billing

Part B allowed, 2024
$74,912
Medicare patients
218
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl11$5,189
Buprenorphine15$2,543
Celecoxib46$1,357
Tizanidine Hcl95$622
Pregabalin27$588
Gabapentin40$328
Duloxetine Hcl19$292
Amitriptyline Hcl14$175

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →